Treatment-resistant cells are a challenge related to prostate cancer and many other cancers, which arises as the disease ...
Scientists at Sanford Burnham Prebys have developed a clearer picture of how crucial machinery in the human cell's recycling ...
Cancer, similar to some parasites that manipulate the brain of their host, hijacks the brain of patients to influence tumor ...
A research team led by Associate Professor Yang Ke from the Hefei Institutes of Physical Science of the Chinese Academy of ...
Genelux Corporation is at the forefront of developing oncolytic immunotherapies. Its lead candidate, olvimulogene ...
Administering immunotherapy when the tumor microenvironment is most susceptible to T cells enhances treatment efficacy in ...
These tumor microenvironment actuated T cells restricted expression of the GD2 CAR to tumor tissue, preventing fatal neurotoxicity while maintaining anti-tumor efficacy. We also found that conditional ...
Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue ...
NuCana plc (NASDAQ: NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering NUC-7738’s composition of matter. This patent (US12,054,510) is ...
There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However, these resistance mechanisms are not yet fully ...
There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the ...
The study examined the impact of factors promoting inflammation in a tumour microenvironment on the progression of prostate ...